CLINICAL_TRIALS
trial_result
· 2019-08-13
Clinical Trial Update: Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis [Phase 2]
Summary
Phase 2 trial update for Crisaborole ointment 2% in atopic dermatitis with biomarker biopsy results completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED | Results posted: 2019-08-13